STOCK TITAN

[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Benson Ella G. reported acquisition or exercise transactions in this Form 4 filing.

ChronoScale Corp director Ella G. Benson received a grant of 200,000 shares of restricted common stock as compensation. The award was granted on May 14, 2026 at no cash purchase price and brings her direct holdings to 200,000 shares.

The grant vests in two equal tranches. 100,000 restricted shares vest on the one-year anniversary of the grant date, and the remaining 100,000 vest on the two-year anniversary. Vesting is conditioned on Benson’s continuous service with ChronoScale and may be adjusted or accelerated under certain conditions.

Positive

  • None.

Negative

  • None.
Insider Benson Ella G.
Role null
Type Security Shares Price Value
Grant/Award Common Stock 200,000 $0.00 --
Holdings After Transaction: Common Stock — 200,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted shares granted 200,000 shares Common Stock award on May 14, 2026
Price per share $0.0000 per share Transaction price for restricted stock grant
Post-grant holdings 200,000 shares Total common shares held directly after transaction
First vesting tranche 100,000 shares Vest on one-year anniversary of May 14, 2026
Second vesting tranche 100,000 shares Vest on two-year anniversary of May 14, 2026
restricted shares financial
"Represents restricted shares of common stock of ChronoScale Corporation"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Grant Date financial
"granted on May 14, 2026 (the "Grant Date") which vest as follows"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vesting financial
"which vest as follows: (i) 100,000 restricted shares will vest"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service with the Issuer"
accelerated vesting financial
"subject to adjustment or accelerated vesting upon certain conditions"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Benson Ella G.

(Last)(First)(Middle)
3811 TURTLE CREEK BOULEVARD
SUITE 2100

(Street)
DALLAS TEXAS 75219

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ChronoScale Corp [ CHRN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/14/2026A200,000(1)A$0200,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted shares of common stock of ChronoScale Corporation (the "Issuer") granted on May 14, 2026 (the "Grant Date") which vest as follows: (i) 100,000 restricted shares will vest on the one-year anniversary of the Grant Date; and (ii) 100,000 restricted shares will vest on the two-year anniversary of the Grant Date, subject to the Reporting Person's continuous service with the Issuer through the applicable vesting date and subject to adjustment or accelerated vesting upon certain conditions.
/s/ Jerome Wong as Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)